EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
EMA recommended 30 veterinary medicines for marketing authorisation in 2025
India’s pharmaceutical sector stands at a pivotal inflection point
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
Elanco expects Befrena to launch in the US in the first half of 2026
The move strengthens Sanofi’s presence in adult immunization by combining Dynavax’s innovative vaccines with Sanofi’s global scale and development capabilities
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
